<DOC>
	<DOCNO>NCT00203736</DOCNO>
	<brief_summary>The purpose study compare efficacy sulfadoxine-pyrimethamine plus artesunate sulfadoxine-pyrimethamine treatment uncomplicated malaria .</brief_summary>
	<brief_title>A Randomised Efficacy Study Combination Antimalarials Treat Uncomplicated Malaria</brief_title>
	<detailed_description>Resistance Plasmodium falciparum anti-malarial drug serious impediment malaria control . In South East African Combination Anti-malarial Therapy ( SEACAT ) evaluation , evaluation phase introduction combination anti-malarial therapy ( CAT ) Mozambique , Swaziland South Africa . In order facilitate formulation effective regional drug policy provide database decision-making implementation CAT , essential vivo response CAT investigate . This achieve SEACAT 01 protocol component SEACAT evaluation describe another file website . However , select Mozambique sit intensity malaria transmission high , direct parallel group comparison monotherapy ( SP ) CAT ( artesunate , AS , plus SP ) conduct accord specific amendment ( Amendment 4 ) SEACAT 01 protocol . Amendment 4 present separate file website clarity .</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Fanasil , pyrimethamine drug combination</mesh_term>
	<mesh_term>Artesunate</mesh_term>
	<mesh_term>Sulfadoxine</mesh_term>
	<mesh_term>Pyrimethamine</mesh_term>
	<mesh_term>Antimalarials</mesh_term>
	<criteria>Male female , old 12 month . Weight &gt; 10 kg . Diagnoses uncomplicated acute P. falciparum malaria parasitaemia 500 000 asexual parasite/mcl blood axillary temperature great equal 37.50C history fever . Documented informed consent . Lives close enough health centre reliable follow . Has receive antimalarial treatment past 7 day . Is infected malarial specie ( subject exclude retrospectively ) . Severely ill ( base WHO Criteria severe malaria ) patient consider , opinion investigator designee , moderately severe malaria ( e.g . prostrate , repeat vomiting , dehydrate ) . Has receive cotrimoxazole chloramphenicol past 7 day . History G6PD deficiency . Is pregnant . Has history allergy sulphonamide ( SP ) artemisinin derivative ( artesunate coartemether ) .</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2005</verification_date>
	<keyword>Malaria</keyword>
	<keyword>Efficacy</keyword>
	<keyword>Pharmacokinetic</keyword>
	<keyword>Gametocyte</keyword>
	<keyword>Molecular Markers</keyword>
	<keyword>Sulfadoxine-pyrimethamine</keyword>
	<keyword>Artesunate</keyword>
	<keyword>Artemisinin</keyword>
</DOC>